Wanbury successfully completes USFDA inspection at its API facility in Patalganga Plant; Stock up 5%

The pharma company successfully completing USFDA inspection at its API facility in Patalganga Plant, Maharashtra.

Oct 03, 2016 05:10 IST India Infoline News Service

Pills Spilling From Bottle
Wanbury Ltd is currently trading at Rs. 47.1, up by Rs. 2.2 or 4.9% from its previous closing of Rs. 44.9 on the BSE after successfully completing USFDA inspection at its API facility in Patalganga Plant, Maharashtra.

The audit was carried out for a period of 4 days from 26th September to 29th September 2016 and concluded successfully.

This is the second plant to be approved by USFDA this year, as earlier Tanuku Plant got approval two months ago in July 2016.

The scrip opened at Rs. 47.1 and has touched a high and low of Rs. 47.1 and Rs. 47.1 respectively. So far 4502 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 89.67 crore.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 93.2 on 31-Dec-2015 and a 52 week low of Rs. 37.3 on 01-Mar-2016. Last one week high and low of the scrip stood at Rs. 48.5 and Rs. 42.6 respectively.

The promoters holding in the company stood at 48.97 % while Institutions and Non-Institutions held 2.92 % and 48.11 % respectively.

The stock is currently trading above its 200 DMA.

Related Story